These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19244369)

  • 1. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
    van Calcar SC; MacLeod EL; Gleason ST; Etzel MR; Clayton MK; Wolff JA; Ney DM
    Am J Clin Nutr; 2009 Apr; 89(4):1068-77. PubMed ID: 19244369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.
    MacLeod EL; Clayton MK; van Calcar SC; Ney DM
    Mol Genet Metab; 2010 Aug; 100(4):303-8. PubMed ID: 20466571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
    Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional management of PKU with glycomacropeptide from cheese whey.
    Ney DM; Gleason ST; van Calcar SC; MacLeod EL; Nelson KL; Etzel MR; Rice GM; Wolff JA
    J Inherit Metab Dis; 2009 Feb; 32(1):32-9. PubMed ID: 18956251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.
    van Calcar SC; Ney DM
    J Acad Nutr Diet; 2012 Aug; 112(8):1201-10. PubMed ID: 22818728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
    Pena MJ; Pinto A; Daly A; MacDonald A; Azevedo L; Rocha JC; Borges N
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.
    Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrogen Balance after the Administration of a Prolonged-Release Protein Substitute for Phenylketonuria as a Single Dose in Healthy Volunteers.
    Scheinin M; Junnila J; Reiner G; MacDonald A; Muntau AC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.